Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3526

Actual shortage: 229 (6%)
Anticipated shortage: 3 (0%)
Avoided shortage: 11 (0%)
Resolved: 3283 (93%)

Discontinuation Reports

366

To be discontinued: 24 (7%)
Discontinued: 342 (93%)
Reversed: 0 (0%)

Late reports

143 (4%)

Overdue reports

32 (13%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-AMLODIPINE 5.0MG TABLET Resolved 2020-07-23 2020-08-07 120979
APO-AMLODIPINE 10MG TABLET Resolved 2021-07-23 2021-08-23 142970
APO-AMLODIPINE 5MG TABLET Resolved 2021-08-16 2021-09-07 144198
APO-AMLODIPINE-ATORVASTATIN 5MG 40MG TABLET Resolved 2017-03-10 2017-04-04 33
APO-AMLODIPINE-ATORVASTATIN 10MG 10MG TABLET Resolved 2017-06-08 2017-08-08 12278
APO-AMLODIPINE-ATORVASTATIN 5MG 20MG TABLET Resolved 2017-07-11 2017-08-08 15420
APO-AMLODIPINE-ATORVASTATIN 5MG 80MG TABLET Resolved 2017-08-14 2017-10-24 19213
APO-AMLODIPINE-ATORVASTATIN 5MG 80MG TABLET Resolved 2018-01-31 2018-07-03 37717
APO-AMLODIPINE-ATORVASTATIN 5MG 10MG TABLET Resolved 2018-02-01 2018-07-03 37945
APO-AMLODIPINE-ATORVASTATIN 10MG 80MG TABLET Resolved 2019-02-13 2019-04-22 75608
APO-AMLODIPINE-ATORVASTATIN 5MG 80MG TABLET Resolved 2019-02-13 2019-04-22 75641
APO-AMLODIPINE-ATORVASTATIN 10MG 40MG TABLET Resolved 2019-12-12 2020-01-15 101082
APO-AMLODIPINE-ATORVASTATIN 10MG 80MG TABLET Resolved 2019-12-12 2020-01-22 101088
APO-AMLODIPINE-ATORVASTATIN 10MG 10MG TABLET Resolved 2020-07-08 2020-07-13 119677
APO-AMLODIPINE-ATORVASTATIN 10MG 40MG TABLET Resolved 2020-07-08 2020-07-13 119683
APO-AMLODIPINE-ATORVASTATIN 10MG 80MG TABLET Resolved 2020-07-08 2020-07-13 119687
APO-AMLODIPINE-ATORVASTATIN 5MG 80MG TABLET Resolved 2020-07-08 2020-07-13 119690
APO-AMLODIPINE-ATORVASTATIN 10MG 80MG TABLET Resolved 2021-01-29 2021-05-26 132703
APO-AMLODIPINE-ATORVASTATIN 5MG 40MG TABLET Resolved 2021-04-23 2021-05-26 137956
APO-AMLODIPINE-ATORVASTATIN 10MG 10MG TABLET Resolved 2021-05-07 2021-05-26 138951

Showing 301 to 320 of 3526

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-QUETIAPINE 25MG TABLET Discontinued 2021-06-25 2021-06-25 141546
APO-QUININE 200MG CAPSULE Discontinued 2018-09-08 2021-05-10 60711
APO-QUININE 300MG CAPSULE Discontinued 2018-09-08 2021-05-10 60714
APO-RABEPRAZOLE 10MG TABLET (ENTERIC-COATED) Discontinued 2018-02-23 2019-09-12 40805
APO-RABEPRAZOLE 20MG TABLET (ENTERIC-COATED) Discontinued 2018-09-08 2018-10-05 60717
APO-RABEPRAZOLE 20MG TABLET (ENTERIC-COATED) Discontinued 2019-01-04 2019-01-04 71201
APO-RABEPRAZOLE 10MG TABLET (ENTERIC-COATED) Discontinued 2019-01-04 2019-01-04 71204
APO-RAMIPRIL 1.25MG CAPSULE Discontinued 2018-09-08 2019-03-29 60720
APO-RANITIDINE TABLET 150MG 150MG TABLET Discontinued 2018-09-08 2019-02-13 60723
APO-RANITIDINE TABLET 150MG 150MG TABLET Discontinued 2018-09-08 2018-12-28 60726
APO-RANITIDINE TABLET 150MG 150MG TABLET Discontinued 2019-01-02 2019-01-09 70810
APO-RANITIDINE TABLET 300MG 300MG TABLET Discontinued 2018-09-08 2018-09-15 60729
APO-RANITIDINE TABLET 300MG 300MG TABLET To be discontinued 2018-09-08 2018-09-08 60732
APO-REPAGLINIDE Discontinued 2018-09-08 2018-09-15 60735
APO-REPAGLINIDE Discontinued 2018-09-08 2018-09-15 60738
APO-REPAGLINIDE Discontinued 2018-09-08 2018-09-15 60741
APO-RILUZOLE 50MG TABLET To be discontinued 2018-09-08 2018-09-08 60744
APO-RISEDRONATE 35MG TABLET Discontinued 2018-09-08 2018-09-15 60747
APO-RISEDRONATE 35MG TABLET Discontinued 2018-10-19 2018-10-19 64965
APO-RISPERIDONE 3.0MG TABLET Discontinued 2018-09-08 2019-06-12 60750

Showing 261 to 280 of 366